Paper41501725
Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma.
Zhang W and 9 others. Cancer Cell Int, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma. Papers, record 41501725. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41501725
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022JJ40793 | Hunan Provincial Natural Science Foundation of China | PubMed | ||
| 82403354 | The National Natural Science Foundation of China | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 42021255 | Correction: Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma. | https://conductscience.org/library/papers/42021255 |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24491301 | Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling. | J Natl Cancer Inst | 2014 | https://conductscience.org/library/papers/24491301 | PubMed |
| 2 | 35077679 | Early human embryonic development: Blastocyst formation to gastrulation. | Dev Cell | 2022 | https://conductscience.org/library/papers/35077679 | PubMed |
| 3 | 28892058 | Glia-specific enhancers and chromatin structure regulate NFIA expression and glioma tumorigenesis. | Nat Neurosci | 2017 | https://conductscience.org/library/papers/28892058 | PubMed |
| 4 | 27713747 | Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation. | Front Immunol | 2016 | https://conductscience.org/library/papers/27713747 | PubMed |
| 5 | 38538696 | Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response. | NPJ Precis Oncol | 2024 | https://conductscience.org/library/papers/38538696 | PubMed |
| 6 | 30787268 | ZFP57 suppress proliferation of breast cancer cells through down-regulation of MEST-mediated Wnt/β-catenin signalling pathway. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/30787268 | PubMed |
| 7 | 36322624 | ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling. | Neuro Oncol | 2023 | https://conductscience.org/library/papers/36322624 | PubMed |
| 8 | 35668574 | Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma. | Cancer Med | 2023 | https://conductscience.org/library/papers/35668574 | PubMed |
| 9 | 37149929 | Genome-wide CRISPR/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasis. | EBioMedicine | 2023 | https://conductscience.org/library/papers/37149929 | PubMed |
| 10 | 34594038 | Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response. | Nat Genet | 2021 | https://conductscience.org/library/papers/34594038 | PubMed |
| 11 | 39055398 | Mime: A flexible machine-learning framework to construct and visualize models for clinical characteristics prediction and feature selection. | Comput Struct Biotechnol J | 2024 | https://conductscience.org/library/papers/39055398 | PubMed |
| 12 | 34608945 | CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018. | Neuro Oncol | 2021 | https://conductscience.org/library/papers/34608945 | PubMed |
| 13 | 28407030 | Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma. | Ann Oncol | 2017 | https://conductscience.org/library/papers/28407030 | PubMed |
| 14 | 33023892 | The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells. | Cancer Discov | 2021 | https://conductscience.org/library/papers/33023892 | PubMed |
| 15 | 38322112 | Machine Learning-Based Integrated Analysis of PANoptosis Patterns in Acute Myeloid Leukemia Reveals a Signature Predicting Survival and Immunotherapy. | Int J Clin Pract | 2024 | https://conductscience.org/library/papers/38322112 | PubMed |
| 16 | 37738997 | Primary brain tumours in adults. | Lancet | 2023 | https://conductscience.org/library/papers/37738997 | PubMed |
| 17 | 34692159 | Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies. | Natl Sci Rev | 2020 | https://conductscience.org/library/papers/34692159 | PubMed |
| 18 | 37192616 | The single-cell and spatial transcriptional landscape of human gastrulation and early brain development. | Cell Stem Cell | 2023 | https://conductscience.org/library/papers/37192616 | PubMed |
| 19 | 38183840 | Glioblastoma vaccines: past, present, and opportunities. | EBioMedicine | 2024 | https://conductscience.org/library/papers/38183840 | PubMed |
| 20 | 34012965 | The Role of Neurodevelopmental Pathways in Brain Tumors. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34012965 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42021255 | Correction: Leveraging the germ layer development patterns to predict prognosis and identify MEST as a novel therapeutic target in glioma. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/42021255 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MEST | 4232 | PubTator's text mining | https://conductscience.org/library/genes/4232 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41501725
GET https://conductscience.org/api/papers/v1/41501725/references?page=2